Dr Will Singleterry | Director Of Business Development
IsoPlexis

Dr Will Singleterry, Director Of Business Development, IsoPlexis

Appearances:



Day 2, April 8 @ 15:40

Single cell functionality serves as a predictive biomarker for overall survival of pancreatic cancer patients treated with GVAX vaccine

last published: 05/Mar/20 10:35 GMT

back to speakers

Sign Up for Event Updates